News Opinion Conversations in Cardiology Conversations in Cardiology: Uncovered Struts on OCT After 12 Years? March 27, 2020
News Daily News More Support for DOAC-Based Double Therapy After PCI for A-fib Patients Todd Neale March 16, 2020
News Daily News Better Adherence to Guideline Advice Pays Off After Acute MI Yael L. Maxwell March 11, 2020
News Daily News Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients Michael O'Riordan March 11, 2020
News Daily News Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS Yael L. Maxwell March 10, 2020
News Daily News New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders Yael L. Maxwell March 06, 2020
News Daily News Validated ARC-HBR Criteria Highlight ‘Eye-opening’ Proportion of PCI Patients at Risk Yael L. Maxwell March 03, 2020
News Daily News Antiplatelets Add Risk in Newly Diagnosed A-fib Patients: GARFIELD-AF Caitlin E. Cox March 02, 2020
News Daily News New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib Shelley Wood February 28, 2020
News Daily News Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights Yael L. Maxwell February 28, 2020
News Conference News CRT 2020 Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation Michael O'Riordan February 26, 2020
News Conference News CRT 2020 PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE Michael O'Riordan February 25, 2020
News Conference News CRT 2020 BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis L.A. McKeown February 25, 2020
News Conference News CRT 2020 Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR L.A. McKeown February 24, 2020
News Daily News Early CVD Readmissions and Mortality Patterns Differ in Canada and the US Yael L. Maxwell February 18, 2020
Presentation JIM 2020 Clinical Crossroads On Optimal Antithrombotic Therapy In Patients Treated With Pci Intravenous Antiplatelet Therapy In High Risk Acs Presenter: Dominick Angiolillo February 13, 2020
Presentation JIM 2020 Intravenous antiplatelet therapy in high risk ACS:GPIIb/IIIa inhibitors are still a good option Presenter: Marco Ferlini February 13, 2020
News Daily News Outcome Differences Between Men and Women With PAD: EUCLID Insights L.A. McKeown February 11, 2020